1 unchanged sentence
Recent Sales of Unregistered Securities
−Removed: During the three months ended March 31, 2026, the Company issued the following unregistered securities:
−Removed: In January 2026, pursuant to a Securities Purchase Agreement dated January 29, 2026, the Company issued 1,388,888 shares of common stock and warrants to purchase 1,388,888 shares of common stock at an exercise price of $9.00 per share to a single institutional investor at a purchase price of $10,000,000.
−Removed: In a subsequent closing under the same Securities Purchase Agreement, the Company issued 86,361 shares of common stock and warrants to purchase 86,361 shares of common stock at an exercise price of $9.00 per share to three investors at an aggregate purchase price of $621,804.11.
−Removed: The offering under that Securities Purchase Agreement terminated on January 31, 2026.
−Removed: In February 2026, pursuant to a second Securities Purchase Agreement dated February 24, 2026, the Company issued an aggregate of 201,390 shares of common stock and warrants to purchase 201,390 shares of common stock at an exercise price of $9.00 per share to four investors at a combined purchase price of $1,450,004 in a closing that took place on February 25, 2026.
−Removed: The offering under the second Securities Purchase Agreement terminated on February 28, 2026.
−Removed: In March 2026, we issued 138,889 shares of common stock and warrants to purchase 138,889 shares of common stock at an exercise price of $9.00 per share to one accredited investor in a private placement at a per-share unit purchase price of $7.20, for aggregate gross proceeds of approximately $1,000,000, pursuant to the Securities Purchase Agreement dated March 20, 2026.
−Removed: In March 2026, 170,000 shares of restricted stock were granted to our Chief Accounting Officer pursuant to the 2023 Equity Incentive Plan.
−Removed: Of these, 53,333 shares of restricted stock vested immediately upon grant, 58,333 shares of restricted stock vest on the first anniversary of the grant date, and 58,334 shares of restricted stock are performance-based and vest upon the achievement of certain performance conditions.
+Added: During the three months ended June 30, 2026, the Company issued the following unregistered securities:
+Added: In April 2026, we issued 277,777 shares of common stock and warrants to purchase 277,777 shares of common stock at an exercise price of $9.00 per share to one accredited investor in a private placement at a per-share unit purchase price of $7.20, for aggregate gross proceeds of $2,000,000, pursuant to the Securities Purchase Agreement dated April 20, 2026.
+Added: In June 2026, pursuant to a Securities Purchase Agreement dated June 11, 2026, the Company issued 6,000 shares of Series A Convertible Preferred Stock to two accredited investors for aggregate gross proceeds of $5,000,000.
None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering.
4 unchanged sentences
Recent Sales of Registered Securities
−Removed: In February 2026, the Company sold 76,648 shares of common stock at $8.40 to $8.97 per share for gross proceeds of approximately $663,727 pursuant to the Equity Purchase Agreement with Mast Hill Fund, LP.
Use of Proceeds
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.